Skip to main content
. 2023 Oct 10;14(2):10.24926/iip.v14i2.5454. doi: 10.24926/iip.v14i2.5454

Table 3.

Unmet Vaccination Needs Identified and Met

Vaccine Type # Unmet Needs n (% of 6,234 patients assessed) Total # Vaccinations Administered n (% of unmet needs) # Vaccinations at Point of Care on Same Day n (% of vaccinations administered) # Vaccinations at Follow-up Visit n (% of vaccinations administered)
Zoster 4,997 (80.2) 3,960A (79.2) 2,259 (57.0) 1,701 (43.0)
Tdap/Td 2,751 (44.1) 620 (22.5) 419 (67.6) 201 (32.4)
Influenza 1,914 (30.7) 1,162 (60.7) 694 (59.7) 468 (40.3)
Pneumococcal 1,391 (22.3) 426 (30.6) 309 (72.5) 117 (27.5)
Hepatitis B 344 (5.5) 50 (14.5) 31 (62.0) 19 (38.0)
Hepatitis A 149 (2.4) 25 (16.8) 20 (80.0) 5 (20.0)
Hepatitis A and BB -- 90 46 (51.1) 44 (48.9)
Measles-mumps-rubella 107 (1.7) 52 (48.6) 47 (90.4) 5 (9.6)
Poliovirus 48 (0.8) 0 0 0
Human Papillomavirus 34 (0.5) 8 (23.5) 4 (50.0) 4 (50.0)
Meningococcal 30 (0.5) 12 (40.0) 9 (75.0) 3 (25.0)
Varicella 24 (0.4) 5 (20.8) 0 1 (100.0)
Total 11,789 (100) 6,405 (54.3) 3,838 (59.9) 2,567 (40.1)
A

969 patients received two doses of recombinant zoster vaccine.

B

Combined Hepatitis A and B vaccine was given.

NOTE: Point of care vaccinations were administered at the pharmacy conducting the assessment of unmet needs.

Follow-up vaccinations were administered at either the initial pharmacy or other care sites.

Tdap/Td – Tetanus and diphtheria toxoids with or without acellular pertussis vaccine